References
- CompareDRoccoANardoneGRisk factors in gastric cancerEur Rev Med Pharmacol Sci201014430230820496539
- BertuccioPChatenoudLLeviFRecent patterns in gastric cancer: a global overviewInt J Cancer2009125366667319382179
- JemalABrayFCenterMMFerlayJWardEFormanDGlobal cancer statisticsCA Cancer J Clin2011612699021296855
- InoueMTsuganeSEpidemiology of gastric cancer in JapanPostgrad Med J20058195741942415998815
- KimHSLeeHJeungHCAdvanced detection of recent changing trends in gastric cancer survival: up-to-date comparison by period analysisJpn J Clin Oncol201141121344135022128316
- ZouXMLiYLWangHGastric cancer cell lines induced by trichostatin AWorld J Gastroenterol200814304810481518720545
- SiegelRMaJZouZJemalACancer statistics, 2014CA Cancer J Clin201464192924399786
- De AngelisRSantMColemanMPCancer survival in Europe 1999–2007 by country and age: results of EUROCARE--5-a population-based studyLancet Oncol2014151233424314615
- UemuraNOkamotoSYamamotoSHelicobacter pylori infection and the development of gastric cancerN Engl J Med20013451178478911556297
- KatoMAsakaMRecent development of gastric cancer preventionJpn J Clin Oncol2012421198799423018579
- ZabaletaJMultifactorial etiology of gastric cancerMethods Mol Biol201286341143522359309
- FigueiredoCGarcia-GonzalezMAMachadoJCMolecular pathogenesis of gastric cancerHelicobacter201318Suppl 1283324011242
- HeasmanSJRidleyAJMammalian Rho GTPases: new insights into their functions from in vivo studiesNat Rev Mol Cell Biol20089969070118719708
- ReidTFuruyashikiTIshizakiTRhotekin, a new putative target for Rho bearing homology to a serine/threonine kinase, PKN, and rhophilin in the rho-binding domainJ Biol Chem19962712313556135608662891
- ItoHIwamotoIMorishitaRPossible role of Rho/Rhotekin signaling in mammalian septin organizationOncogene200524477064707216007136
- SudoKItoHIwamotoIMorishitaRAsanoTNagataKIdentification of a cell polarity-related protein, Lin-7B, as a binding partner for a Rho effector, Rhotekin, and their possible interaction in neuronsNeurosci Res200656434735516979770
- ItoHIwamotoIMorishitaRNozawaYAsanoTNagataKIdentification of a PDZ protein, PIST, as a binding partner for Rho effector Rhotekin: biochemical and cell-biological characterization of Rhotekin-PIST interactionBiochem J2006397338939816646955
- WangHHanMWhetsellWJrTax-interacting protein 1 coordinates the spatiotemporal activation of Rho GTPases and regulates the infiltrative growth of human glioblastomaOncogene201433121558156923563176
- ReynaudCFabreSJalinotPThe PDZ protein TIP-1 interacts with the Rho effector rhotekin and is involved in Rho signaling to the serum response elementJ Biol Chem200027543339623396810940294
- NagataKItoHIwamotoIMorishitaRAsanoTInteraction of a multi-domain adaptor protein, vinexin, with a Rho-effector, RhotekinMed Mol Morphol200942191519294487
- ChenMBresnickARO’ConnorKLCoupling S100A4 to Rhotekin alters Rho signaling output in breast cancer cellsOncogene201332323754376422964635
- LiuCAWangMJChiCWWuCWChenJYOverexpression of rho effector rhotekin confers increased survival in gastric adenocarcinomaJ Biomed Sci200411566167015316142
- FanJMaLJXiaSJAssociation between clinical characteristics and expression abundance of RTKN gene in human bladder carcinoma tissues from Chinese patientsJ Cancer Res Clin Oncol2005131315716215599595
- LiuCAWangMJChiCWWuCWChenJYRho/Rhotekin-mediated NF-kappaB activation confers resistance to apoptosisOncogene200423548731874215480428
- FarneboMBykovVJWimanKGThe p53 tumor suppressor: a master regulator of diverse cellular processes and therapeutic target in cancerBiochem Biophys Res Commun20103961858920494116
- SoussiTThe p53 pathway and human cancerBr J Surg200592111331133216240283
- MullerPAVousdenKHp53 mutations in cancerNat Cell Biol20131512823263379
- WadeMLiYCWahlGMMDM2, MDMX and p53 in oncogenesis and cancer therapyNat Rev Cancer2013132839623303139
- MullerPAVousdenKHp53 mutations in cancerNat Cell Biol20131512823263379
- TangYZhaoWChenYZhaoYGuWAcetylation is indispensable for p53 activationCell2008133461262618485870
- ZhangLJLuRSongYNKnockdown of anion exchanger 2 suppressed the growth of ovarian cancer cells via mTOR/p70S6K1 signalingSci Rep201771636228743911
- RyanKMErnstMKRiceNRVousdenKHRole of NF-kappaB in p53-mediated programmed cell deathNature2000404678089289710786798
- PuszynskiKBertolussoRLipniackiTCrosstalk between p53 and nuclear factor-B systems: pro- and anti-apoptotic functions of NF-BIET Syst Biol20093535636721028926
- JuanLJShiaWJChenMHHistone deacetylases specifically down-regulate p53-dependent gene activationJ Biol Chem200027527204362044310777477
- YangGJZhongHJKoCNIdentification of a rhodium(iii) complex as a Wee1 inhibitor against TP53-mutated triple-negative breast cancer cellsChem Commun2018542024632466
- KjWZhongHJYangGSmall molecule Pin1 inhibitor blocking NF-κB signaling in prostate cancer cellsChem Asian J201813327527929288531
- KimSJLeeHWBaekJHActivation of nuclear PTEN by inhibition of Notch signaling induces G2/M cell cycle arrest in gastric cancerOncogene201635225126025823029
- WuKJZhongHJLiGStructure-based identification of a NEDD8-activating enzyme inhibitor via drug repurposingEur J Med Chem20181431021102729232579
- GartelALRadhakrishnanSKLost in transcription: p21 repression, mechanisms, and consequencesCancer Res200565103980398515899785
- LuoCZhuYJiangTMatrine induced gastric cancer MKN45 cells apoptosis via increasing pro-apoptotic molecules of Bcl-2 familyToxicology2007229324525217134813